Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Kostnader för bipolär sjukdom, depression, schizofreni och ångest. Rätt behandlingar kan få stora positiva samhällsekonomiska effekter
Engelsk titel: Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects Läs online Författare: Ekman, Mattias ; Granström, Ola ; Omerov, Sead ; Jakob, Johanna ; Landen, Mikael Språk: Swe Antal referenser: 28 Dokumenttyp: Artikel UI-nummer: 14097283

Tidskrift

Läkartidningen 2014;111(34-35)1362-4 ISSN 0023-7205 E-ISSN 1652-7518 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

We present estimates of the societal cost of bipolar disorder, depression, and schizophrenia for patients treated in psychiatric care in Sweden, and add previously unpublished data for generalized anxiety disorder. Retrospective resource use data on outpatient and inpatient care, as well as ICD-10 diagnoses and Global Assessment of Functioning, were obtained from the Northern Stockholm psychiatric clinic. National registers were used for estimating costs of pharmaceuticals and productivity losses. The yearly cost per patient was 259 000 SEK for bipolar disorder, 159 000 SEK for depression, 156 000 SEK for generalized anxiety disorder and 509 000 SEK for schizophrenia (1 € = 9.23 SEK). The total costs for all four diagnoses were 75 billion SEK in 2008, with indirect costs due to productivity losses representing 75%. The high indirect costs for these psychiatric diagnoses suggest that treatments which improve functioning have a large potential to reduce the total societal costs.